Ads
related to: pfizer stock performance 2024 todaylp.stockstotrade.com has been visited by 10K+ users in the past month
signup.chaikinanalytics.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Pharmaceuticals giant Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings ...
*Stock Advisor returns as of February 3, 2025 ... Thank you for joining us today. 2024 was a strong year of execution and performance for Pfizer.
Price Action: PFE stock is down 1.49% at $26.40 at the last check on Tuesday. Read Next: Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030
Here is whether Pfizer stock might be a buy today -- and why. ... Pfizer grew revenue by 14% year over year in the third quarter of 2024. You can see below that Pfizer's trailing-12-month ...
Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...
The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth stra Pfizer lifts profit forecast as CEO sees reason for optimism in 2024 Skip to main ...